Atacama Therapeutics, Inc.
PrivateLast Round
Series A
Dec 1, 2023
Total Funding Raised
$2.83M
Company Overview
Atacama Therapeutics, Inc. is a biotechnology company that develops targeted small molecule therapies for dermatological conditions such as Acne Vulgaris and hyperhidrosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Atacama Therapeutics, Inc. Comparables
Compare Atacama Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neuropore Therapies, Inc. | 85% | |
| Vanqua Bio | 84% | |
| PharmatrophiX | 83% |
Atacama Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 1, 2023 |
Atacama Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KittyHawk Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2023
$2M round with KittyHawk Ventures and Roy Peterkofsky.
Atacama Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Atacama Therapeutics, Inc.'s valuation, stock price, and market status.
Is Atacama Therapeutics, Inc. a public or private company?
Atacama Therapeutics, Inc. is a private company.
What is the current stock price of Atacama Therapeutics, Inc.?
Atacama Therapeutics, Inc. is a private company with no public stock price. Caplight tracks Atacama Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Atacama Therapeutics, Inc. worth (valuation)?
Valuation information for Atacama Therapeutics, Inc. is not publicly available.
Can I buy Atacama Therapeutics, Inc. stock?
Atacama Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Atacama Therapeutics, Inc.'s last funding round?
Atacama Therapeutics, Inc.'s most recent funding round was Series A on December 1, 2023.
Who are the main investors in Atacama Therapeutics, Inc.?
Key investors in Atacama Therapeutics, Inc. include KittyHawk Ventures.
Will Atacama Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Atacama Therapeutics, Inc..
How can I track Atacama Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Atacama Therapeutics, Inc.'s secondary market activity and sign up for updates.